# Geisinger Medical Center Blood Bank – FDA Inspection, Jan 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/geisinger-medical-center-blood-bank/bff246f3-015a-4173-be20-e0dad7891dce
Source feed: FDA_Inspections

> FDA inspection 1077348 of Geisinger Medical Center Blood Bank, January 24, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 606. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1077348
- Company Name: Geisinger Medical Center Blood Bank
- Inspection Date: 2019-01-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1119128 - 2020-01-14
- FDA Inspection 1049028 - 2018-04-03
- FDA Inspection 993518 - 2016-11-16
- FDA Inspection 971865 - 2016-05-11
- FDA Inspection 902585 - 2014-11-06

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/geisinger-medical-center-blood-bank/9f4506a2-4fe0-4222-a726-a699e9c7e943

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d